Cargando…
Transcriptional coactivator MED1 in the interface of anti-estrogen and anti-HER2 therapeutic resistance
Breast cancer is one of the most common cancer and leading causes of death in women in the United States and Worldwide. About 90% of breast cancers belong to ER+ or HER2+ subtypes and are driven by key breast cancer genes Estrogen Receptor and HER2, respectively. Despite the advances in anti-estroge...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255246/ https://www.ncbi.nlm.nih.gov/pubmed/35800368 http://dx.doi.org/10.20517/cdr.2022.33 |